Gilmore Neil O'Neill, CEO at Editas Medicine, sold EDIT on Sep 3, 2026

Data as of Oct 16

▼ SELL$15.6K5,124 shares at $3.04Gilmore Neil O'Neill CEOEDIT Editas Medicine, Inc.

Watch EDIT

Traded: Sep 3, 2026
Disclosed: Sep 4, 2026
Filed: 1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

EDITSimilar stocks (S&P 500 (SPY)), rebased to EDIT's price on the disclosure day

EDIT since disclosure

−27.2%

after the sale

Similar stocks (SPY) since disclosure

−0.9%

S&P 500 (SPY)

Change in closing price from Sep 4, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on EDIT →